Lexaria reports additional patent grants in the US, Canada and Europe
Lexaria Bioscience has reported four additional patent awards in the US, Canada and Europe, bringing its stated portfolio to 70 patents granted worldwide.
Topic Intelligence
Articles and insights tagged Cannabidiol (CBD) on FAQSIR.
Lexaria Bioscience has reported four additional patent awards in the US, Canada and Europe, bringing its stated portfolio to 70 patents granted worldwide.
Lexaria Bioscience reported results from animal study GLP-1-A26-1, which evaluated DehydraTECH-CBD and DehydraTECH-semaglutide formulations and included a reported 566% improvement in mean brain absorption for one DHT-CBD formulation.